Daniel P Kelly Selected Research

Ketosis

1/2022	Acute Echocardiographic Effects of Exogenous Ketone Administration in Healthy Participants.
1/2022	Comparison of Exogenous Ketone Administration Versus Dietary Carbohydrate Restriction on Myocardial Glucose Suppression: A Crossover Clinical Trial.
1/2020	Implications of Altered Ketone Metabolism and Therapeutic Ketosis in Heart Failure.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniel P Kelly Research Topics

Disease

18	Heart Failure 01/2022 - 04/2002
9	Cardiomyopathies (Cardiomyopathy) 01/2013 - 01/2002
7	Obesity 01/2019 - 02/2005
7	Insulin Resistance 01/2019 - 08/2003
6	Cardiomegaly (Heart Hypertrophy) 11/2014 - 04/2002
5	Hypertension (High Blood Pressure) 02/2021 - 01/2003
5	Mitochondrial Diseases (Mitochondrial Disease) 11/2019 - 01/2005
4	Hypertrophy 01/2019 - 01/2002
3	Inflammation (Inflammations) 11/2022 - 01/2021
3	Ketosis 01/2022 - 01/2020
3	Respiratory Insufficiency (Respiratory Failure) 01/2022 - 05/2017
3	Critical Illness (Critically Ill) 01/2022 - 01/2017
3	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2013 - 07/2002
3	Myocardial Ischemia (Ischemic Heart Diseases) 09/2010 - 01/2006
3	Diabetes Mellitus 01/2010 - 01/2002
3	Diabetic Cardiomyopathies 12/2004 - 01/2002
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 10/2010
2	Muscular Atrophy (Muscle Atrophy) 01/2020 - 11/2019
2	Melanoma (Melanoma, Malignant) 01/2019 - 12/2014
2	Paralysis (Palsy) 07/2016 - 02/2014
2	Ventricular Dysfunction 04/2011 - 01/2002
2	Reperfusion Injury 12/2007 - 01/2006
2	Ischemia 12/2007 - 01/2006
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 01/2022
1	Tracheitis 01/2021
1	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2021
1	Atrophy 11/2019
1	Fibrosis (Cirrhosis) 10/2019
1	Aortic Valve Insufficiency (Aortic Regurgitation) 10/2018
1	Shock 05/2017
1	Coma (Comas) 05/2017
1	Lactic Acidosis 05/2017
1	Parkinson Disease (Parkinson's Disease) 04/2015
1	Premature Aging 07/2014
1	Esophageal Atresia 02/2014
1	Barth Syndrome 01/2014
1	Muscular Diseases (Myopathy) 06/2013

Drug/Important Bio-Agent (IBA)

19	PPAR alphaIBA 02/2013 - 01/2002
17	Fatty Acids (Saturated Fatty Acids)IBA 11/2018 - 01/2002
12	Glucose (Dextrose)FDA LinkGeneric 11/2022 - 01/2002
7	KetonesIBA 01/2022 - 02/2016
7	LipidsIBA 11/2019 - 02/2003
6	EnzymesIBA 02/2016 - 04/2002
5	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 11/2019 - 01/2002
4	Insulin (Novolin)FDA Link 11/2018 - 09/2005
4	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 04/2017 - 04/2002
4	Proteins (Proteins, Gene)FDA Link 11/2014 - 11/2003
3	Pharmaceutical PreparationsIBA 01/2019 - 10/2010
2	EstersIBA 01/2022 - 01/2021
2	Adenosine Triphosphate (ATP)IBA 01/2022 - 07/2008
2	ProteomeIBA 01/2022 - 01/2020
2	Mitochondrial Proteins (Mitochondrial Protein)IBA 01/2020 - 02/2016
2	Lysine (L-Lysine)FDA Link 01/2020 - 02/2016
2	CalciumIBA 11/2019 - 10/2019
2	PPAR gammaIBA 02/2013 - 03/2004
2	CytokinesIBA 01/2013 - 09/2005
2	Biological ProductsIBA 10/2011 - 03/2006
2	Triglycerides (Triacylglycerol)IBA 09/2005 - 02/2003
2	Transcription Factors (Transcription Factor)IBA 12/2004 - 04/2002
1	Fluorine-18IBA 11/2022
1	Nonesterified Fatty Acids (NEFA)IBA 01/2022
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2022
1	SaltsIBA 02/2021
1	Acetates (Acetic Acid Esters)FDA Link 02/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	Ketone BodiesIBA 01/2021
1	Oxygen (Dioxygen)IBA 03/2020
1	Sodium-Glucose Transport ProteinsIBA 01/2020
1	Peptides (Polypeptides)IBA 01/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019
1	salicylhydroxamic acid (SHAM)IBA 01/2019
1	3-Hydroxybutyric Acid (beta-Hydroxybutyric Acid)IBA 01/2019
1	Messenger RNA (mRNA)IBA 10/2018
1	empagliflozinIBA 08/2017
1	TabletsIBA 05/2017
1	Lactic Acid (Lactate)FDA LinkGeneric 05/2017
1	Carbamazepine (Tegretol)FDA LinkGeneric 05/2017
1	barbituric acid (barbiturate)IBA 05/2017
1	Hydroxybutyrate Dehydrogenase (3 Hydroxybutyrate Dehydrogenase)IBA 02/2016
1	Acetyl Coenzyme A (Acetyl-CoA)IBA 02/2016
1	SynucleinsIBA 04/2015
1	AntioxidantsIBA 04/2015
1	CarbonIBA 11/2014
1	proto-oncogene proteins pimIBA 07/2014
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2014
1	Cardiolipins (Cardiolipin)IBA 01/2014
1	MicroRNAs (MicroRNA)IBA 06/2013

Therapy/Procedure

9	Therapeutics 01/2022 - 12/2007
2	Ketogenic Diet 11/2022 - 01/2022
2	Mechanical Ventilators (Ventilator) 01/2021 - 07/2016
2	Artificial Respiration (Mechanical Ventilation) 01/2021 - 01/2019
2	Bed Rest (Bedrest) 01/2020 - 11/2019
2	Central Venous Catheters 07/2016 - 02/2014
1	Extracorporeal Membrane Oxygenation 01/2022
1	Noninvasive Ventilation 01/2019
1	Immunomodulation 01/2017
1	Thoracotomy 07/2016
1	Ligation 01/2015
1	Catheters 02/2014
1	Length of Stay 02/2014